Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115394) titled 'OCTA-Based non-invasive assessment of retinal immune cells for prognosis in posterior uveitis: a prospective, observational study' on Dec. 25, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Non-infectious posterior uveitis
Intervention:
The Corticosteroid Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-25
Target Sample Size: The Corticosteroid Group:120;The Immunosuppressant Group:47;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301...